soul trial oral semaglutide cardiovascular outcomes 2025 nejm 2024 Oral Semaglutide's Impact on Cardiovascular Events in Type 2 Diabetes Patients with Cardiovascular and Kidney Disease: SOUL Trial Results Frontiers | Effects of subcutaneous

Safety Considerations With Compounded GLP-1 Medications Discussions about GLP-1 microdosing often involve compounded medications, which are versions of tirzepatide or semaglutide mixed by compounding pharmacies rather than manufactured by the original drug maker

Many patients feel refreshed and more focused after just one session

For those with blood disorders like thrombocytopenia (low platelet count) or von Willebrand disease , bruising risks are significantly higher

Use a syringe with high dead space and you systematically lose a small portion of every dose

Slows Digestion and Increases Satiety GLP-1 also slows digestion and contributes to a full sensation